The purpose of this study is to determine if patients with recurrent pregnancy loss or unexplained infertility have an altered uterine gene expression or uterine microbiome (micro-organism composition) during the window of embryo implantation. Furthermore we would like to assess for women with an abnormal uterine gene expression whether vaginal progesterone medication improves or alters gene expression and for women with an abnormal microbiome whether antibiotic treatment followed by probiotic treatment normalizes the microbiome.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Abnormal Microbiome Bacterial Sequencing
Timeframe: 1 month
Abnormal Endometrial Receptivity Array
Timeframe: 1 month
Normalized Microbiome Bacterial Sequencing
Timeframe: 3-6 months
Normalized Endometrial Receptivity Array
Timeframe: 3-6 months